<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>While both primary and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e> virus (HSV) in vitro <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> of a Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-derived cell line (Raji) were similarly characterized by the induction of IgG-Fe receptors in about 50% of cells, the persistent <z:e sem="disease" ids="C1504513" disease_type="Disease or Syndrome" abbrv="">HSV infection</z:e> of Raji cells was also accompanied by an induction of surface-bound IgM in approximately 80% of cells </plain></SENT>
<SENT sid="1" pm="."><plain>This IgM induction was suppressed by treating the infected cells with interferon, but not with <z:chebi fb="0" ids="15732">phosphonoacetic acid</z:chebi>, an inhibitor of <z:e sem="disease" ids="C0019340" disease_type="Disease or Syndrome" abbrv="">herpes</z:e> virus DNA polymerase activity </plain></SENT>
<SENT sid="2" pm="."><plain>The fact that only the cell population which had lost this IgM expression was superinfectable would suggest that this Ig may play a protective role (e.g. antibody activity?) against HSV </plain></SENT>
</text></document>